nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP1A2—Carmustine—brain cancer	0.198	0.351	CbGbCtD
Methoxsalen—CYP3A4—Temozolomide—brain cancer	0.15	0.265	CbGbCtD
Methoxsalen—CYP3A4—Lomustine—brain cancer	0.127	0.225	CbGbCtD
Methoxsalen—CYP2A13—nose—brain cancer	0.122	0.873	CbGeAlD
Methoxsalen—CYP1A2—Etoposide—brain cancer	0.0587	0.104	CbGbCtD
Methoxsalen—CYP3A4—Etoposide—brain cancer	0.0308	0.0545	CbGbCtD
Methoxsalen—CYP2A13—CYP2E1 reactions—CYP2C9—brain cancer	0.024	0.17	CbGpPWpGaD
Methoxsalen—CYP2A13—Xenobiotics—CYP2C9—brain cancer	0.0149	0.105	CbGpPWpGaD
Methoxsalen—CYP2A13—endocrine gland—brain cancer	0.0084	0.0601	CbGeAlD
Methoxsalen—Lupus erythematosus—Hydroxyurea—brain cancer	0.00812	0.0527	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Procarbazine—brain cancer	0.00657	0.0427	CcSEcCtD
Methoxsalen—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00644	0.0456	CbGpPWpGaD
Methoxsalen—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00619	0.0438	CbGpPWpGaD
Methoxsalen—CYP2A13—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00618	0.0437	CbGpPWpGaD
Methoxsalen—CYP2A13—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.0061	0.0431	CbGpPWpGaD
Methoxsalen—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00563	0.0399	CbGpPWpGaD
Methoxsalen—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.00546	0.0355	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Hydroxyurea—brain cancer	0.00508	0.033	CcSEcCtD
Methoxsalen—CYP2A13—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00501	0.0354	CbGpPWpGaD
Methoxsalen—Digestion impaired—Hydroxyurea—brain cancer	0.00452	0.0294	CcSEcCtD
Methoxsalen—Blister—Hydroxyurea—brain cancer	0.0042	0.0272	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Carmustine—brain cancer	0.00411	0.0267	CcSEcCtD
Methoxsalen—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.00399	0.0282	CbGpPWpGaD
Methoxsalen—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00395	0.0279	CbGpPWpGaD
Methoxsalen—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00384	0.0272	CbGpPWpGaD
Methoxsalen—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00359	0.0254	CbGpPWpGaD
Methoxsalen—Digestion impaired—Temozolomide—brain cancer	0.00353	0.023	CcSEcCtD
Methoxsalen—Tenderness—Hydroxyurea—brain cancer	0.00347	0.0225	CcSEcCtD
Methoxsalen—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.00297	0.021	CbGpPWpGaD
Methoxsalen—Skin exfoliation—Hydroxyurea—brain cancer	0.00289	0.0188	CcSEcCtD
Methoxsalen—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00286	0.0202	CbGpPWpGaD
Methoxsalen—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00274	0.0194	CbGpPWpGaD
Methoxsalen—CYP2A13—Biological oxidations—CYP2C9—brain cancer	0.00266	0.0188	CbGpPWpGaD
Methoxsalen—CYP2A13—Metapathway biotransformation—CYP2C9—brain cancer	0.00262	0.0186	CbGpPWpGaD
Methoxsalen—Herpes simplex—Temozolomide—brain cancer	0.00256	0.0166	CcSEcCtD
Methoxsalen—Infection—Carboplatin—brain cancer	0.00249	0.0162	CcSEcCtD
Methoxsalen—Skin exfoliation—Carmustine—brain cancer	0.00233	0.0152	CcSEcCtD
Methoxsalen—Dermatitis bullous—Hydroxyurea—brain cancer	0.0023	0.0149	CcSEcCtD
Methoxsalen—Skin exfoliation—Temozolomide—brain cancer	0.00226	0.0146	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Procarbazine—brain cancer	0.00224	0.0145	CcSEcCtD
Methoxsalen—Infection—Lomustine—brain cancer	0.00218	0.0142	CcSEcCtD
Methoxsalen—Body temperature increased—Carboplatin—brain cancer	0.00198	0.0129	CcSEcCtD
Methoxsalen—Inflammation—Etoposide—brain cancer	0.00195	0.0127	CcSEcCtD
Methoxsalen—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.0019	0.0134	CbGpPWpGaD
Methoxsalen—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00182	0.0129	CbGpPWpGaD
Methoxsalen—Skin exfoliation—Etoposide—brain cancer	0.0018	0.0117	CcSEcCtD
Methoxsalen—Arrhythmia—Procarbazine—brain cancer	0.00175	0.0114	CcSEcCtD
Methoxsalen—CYP2A6—cerebellum—brain cancer	0.00175	0.0125	CbGeAlD
Methoxsalen—Body temperature increased—Lomustine—brain cancer	0.00174	0.0113	CcSEcCtD
Methoxsalen—Tension—Procarbazine—brain cancer	0.00168	0.0109	CcSEcCtD
Methoxsalen—Nervousness—Procarbazine—brain cancer	0.00166	0.0108	CcSEcCtD
Methoxsalen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00166	0.0117	CbGpPWpGaD
Methoxsalen—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00164	0.0116	CbGpPWpGaD
Methoxsalen—Dry skin—Temozolomide—brain cancer	0.00157	0.0102	CcSEcCtD
Methoxsalen—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00146	0.0104	CbGpPWpGaD
Methoxsalen—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00143	0.0101	CbGpPWpGaD
Methoxsalen—CYP2A6—brain—brain cancer	0.00142	0.0102	CbGeAlD
Methoxsalen—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00141	0.00996	CbGpPWpGaD
Methoxsalen—Oedema—Procarbazine—brain cancer	0.00139	0.00905	CcSEcCtD
Methoxsalen—Infection—Procarbazine—brain cancer	0.00139	0.009	CcSEcCtD
Methoxsalen—Depression—Carmustine—brain cancer	0.00136	0.00886	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Temozolomide—brain cancer	0.00135	0.00879	CcSEcCtD
Methoxsalen—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00134	0.00951	CbGpPWpGaD
Methoxsalen—Erythema—Hydroxyurea—brain cancer	0.00132	0.00859	CcSEcCtD
Methoxsalen—Depression—Temozolomide—brain cancer	0.00132	0.00856	CcSEcCtD
Methoxsalen—Nausea—Lomustine—brain cancer	0.0013	0.00847	CcSEcCtD
Methoxsalen—Hypotension—Procarbazine—brain cancer	0.0013	0.00846	CcSEcCtD
Methoxsalen—Insomnia—Procarbazine—brain cancer	0.00126	0.00819	CcSEcCtD
Methoxsalen—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00124	0.00878	CbGpPWpGaD
Methoxsalen—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00123	0.00874	CbGpPWpGaD
Methoxsalen—Ill-defined disorder—Hydroxyurea—brain cancer	0.00123	0.00797	CcSEcCtD
Methoxsalen—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00122	0.00862	CbGpPWpGaD
Methoxsalen—Malaise—Hydroxyurea—brain cancer	0.00119	0.00774	CcSEcCtD
Methoxsalen—Feeling abnormal—Procarbazine—brain cancer	0.00115	0.00746	CcSEcCtD
Methoxsalen—Discomfort—Hydroxyurea—brain cancer	0.00111	0.00722	CcSEcCtD
Methoxsalen—Urticaria—Procarbazine—brain cancer	0.00111	0.00719	CcSEcCtD
Methoxsalen—Body temperature increased—Procarbazine—brain cancer	0.0011	0.00716	CcSEcCtD
Methoxsalen—Arrhythmia—Carmustine—brain cancer	0.0011	0.00712	CcSEcCtD
Methoxsalen—Oedema—Hydroxyurea—brain cancer	0.00108	0.00701	CcSEcCtD
Methoxsalen—Infection—Hydroxyurea—brain cancer	0.00107	0.00696	CcSEcCtD
Methoxsalen—Erythema—Carmustine—brain cancer	0.00107	0.00694	CcSEcCtD
Methoxsalen—Skin disorder—Hydroxyurea—brain cancer	0.00105	0.00681	CcSEcCtD
Methoxsalen—CYP1A2—endocrine gland—brain cancer	0.00104	0.00746	CbGeAlD
Methoxsalen—Erythema—Temozolomide—brain cancer	0.00103	0.00671	CcSEcCtD
Methoxsalen—CYP1A1—endocrine gland—brain cancer	0.00103	0.00736	CbGeAlD
Methoxsalen—Hypersensitivity—Procarbazine—brain cancer	0.00103	0.00667	CcSEcCtD
Methoxsalen—CYP1A1—head—brain cancer	0.00102	0.00727	CbGeAlD
Methoxsalen—Dysgeusia—Temozolomide—brain cancer	0.00101	0.00657	CcSEcCtD
Methoxsalen—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.001	0.00711	CbGpPWpGaD
Methoxsalen—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.001	0.00708	CbGpPWpGaD
Methoxsalen—Pruritus—Procarbazine—brain cancer	0.000986	0.00641	CcSEcCtD
Methoxsalen—Ill-defined disorder—Temozolomide—brain cancer	0.000958	0.00622	CcSEcCtD
Methoxsalen—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000957	0.00677	CbGpPWpGaD
Methoxsalen—Dyspepsia—Hydroxyurea—brain cancer	0.00095	0.00617	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000932	0.00605	CcSEcCtD
Methoxsalen—Malaise—Temozolomide—brain cancer	0.000931	0.00605	CcSEcCtD
Methoxsalen—Vertigo—Temozolomide—brain cancer	0.000928	0.00603	CcSEcCtD
Methoxsalen—CYP1A1—central nervous system—brain cancer	0.000928	0.00664	CbGeAlD
Methoxsalen—Dizziness—Procarbazine—brain cancer	0.000922	0.00599	CcSEcCtD
Methoxsalen—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000911	0.00645	CbGpPWpGaD
Methoxsalen—Feeling abnormal—Hydroxyurea—brain cancer	0.000889	0.00577	CcSEcCtD
Methoxsalen—Rash—Procarbazine—brain cancer	0.000879	0.00571	CcSEcCtD
Methoxsalen—Dermatitis—Procarbazine—brain cancer	0.000878	0.0057	CcSEcCtD
Methoxsalen—Headache—Procarbazine—brain cancer	0.000873	0.00567	CcSEcCtD
Methoxsalen—Oedema—Carmustine—brain cancer	0.000872	0.00566	CcSEcCtD
Methoxsalen—Discomfort—Temozolomide—brain cancer	0.000869	0.00564	CcSEcCtD
Methoxsalen—Infection—Carmustine—brain cancer	0.000867	0.00563	CcSEcCtD
Methoxsalen—Body temperature increased—Hydroxyurea—brain cancer	0.000853	0.00554	CcSEcCtD
Methoxsalen—Oedema—Temozolomide—brain cancer	0.000843	0.00547	CcSEcCtD
Methoxsalen—Infection—Temozolomide—brain cancer	0.000837	0.00544	CcSEcCtD
Methoxsalen—Nausea—Procarbazine—brain cancer	0.000828	0.00538	CcSEcCtD
Methoxsalen—Skin disorder—Temozolomide—brain cancer	0.000819	0.00532	CcSEcCtD
Methoxsalen—Hypotension—Carmustine—brain cancer	0.000815	0.00529	CcSEcCtD
Methoxsalen—Dysgeusia—Etoposide—brain cancer	0.000809	0.00526	CcSEcCtD
Methoxsalen—Hypersensitivity—Hydroxyurea—brain cancer	0.000795	0.00516	CcSEcCtD
Methoxsalen—Muscle spasms—Etoposide—brain cancer	0.000795	0.00516	CcSEcCtD
Methoxsalen—Insomnia—Carmustine—brain cancer	0.000789	0.00512	CcSEcCtD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000787	0.00557	CbGpPWpGaD
Methoxsalen—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000777	0.0055	CbGpPWpGaD
Methoxsalen—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000771	0.00545	CbGpPWpGaD
Methoxsalen—Ill-defined disorder—Etoposide—brain cancer	0.000767	0.00498	CcSEcCtD
Methoxsalen—Insomnia—Temozolomide—brain cancer	0.000762	0.00495	CcSEcCtD
Methoxsalen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000757	0.00535	CbGpPWpGaD
Methoxsalen—CYP3A4—endocrine gland—brain cancer	0.000755	0.0054	CbGeAlD
Methoxsalen—Gastrointestinal disorder—Carmustine—brain cancer	0.000753	0.00489	CcSEcCtD
Methoxsalen—Malaise—Etoposide—brain cancer	0.000745	0.00484	CcSEcCtD
Methoxsalen—Vertigo—Etoposide—brain cancer	0.000743	0.00482	CcSEcCtD
Methoxsalen—Dyspepsia—Temozolomide—brain cancer	0.000742	0.00482	CcSEcCtD
Methoxsalen—CYP1A1—brain—brain cancer	0.000736	0.00527	CbGeAlD
Methoxsalen—Gastrointestinal disorder—Temozolomide—brain cancer	0.000728	0.00473	CcSEcCtD
Methoxsalen—Feeling abnormal—Carmustine—brain cancer	0.000719	0.00467	CcSEcCtD
Methoxsalen—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000714	0.00505	CbGpPWpGaD
Methoxsalen—Dizziness—Hydroxyurea—brain cancer	0.000714	0.00463	CcSEcCtD
Methoxsalen—Discomfort—Etoposide—brain cancer	0.000695	0.00451	CcSEcCtD
Methoxsalen—Feeling abnormal—Temozolomide—brain cancer	0.000695	0.00451	CcSEcCtD
Methoxsalen—Body temperature increased—Carmustine—brain cancer	0.00069	0.00448	CcSEcCtD
Methoxsalen—CYP3A4—central nervous system—brain cancer	0.000681	0.00487	CbGeAlD
Methoxsalen—Rash—Hydroxyurea—brain cancer	0.00068	0.00442	CcSEcCtD
Methoxsalen—Dermatitis—Hydroxyurea—brain cancer	0.00068	0.00441	CcSEcCtD
Methoxsalen—Headache—Hydroxyurea—brain cancer	0.000676	0.00439	CcSEcCtD
Methoxsalen—Infection—Etoposide—brain cancer	0.00067	0.00435	CcSEcCtD
Methoxsalen—Urticaria—Temozolomide—brain cancer	0.00067	0.00435	CcSEcCtD
Methoxsalen—Body temperature increased—Temozolomide—brain cancer	0.000666	0.00433	CcSEcCtD
Methoxsalen—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000659	0.00466	CbGpPWpGaD
Methoxsalen—Skin disorder—Etoposide—brain cancer	0.000655	0.00425	CcSEcCtD
Methoxsalen—Hypersensitivity—Carmustine—brain cancer	0.000643	0.00417	CcSEcCtD
Methoxsalen—Nausea—Hydroxyurea—brain cancer	0.000641	0.00416	CcSEcCtD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000638	0.00452	CbGpPWpGaD
Methoxsalen—Hypotension—Etoposide—brain cancer	0.00063	0.00409	CcSEcCtD
Methoxsalen—Hypersensitivity—Temozolomide—brain cancer	0.000621	0.00403	CcSEcCtD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000608	0.0043	CbGpPWpGaD
Methoxsalen—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.0006	0.00424	CbGpPWpGaD
Methoxsalen—Pruritus—Temozolomide—brain cancer	0.000596	0.00387	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Etoposide—brain cancer	0.000582	0.00378	CcSEcCtD
Methoxsalen—Dizziness—Carmustine—brain cancer	0.000577	0.00375	CcSEcCtD
Methoxsalen—Dizziness—Temozolomide—brain cancer	0.000557	0.00362	CcSEcCtD
Methoxsalen—Feeling abnormal—Etoposide—brain cancer	0.000556	0.00361	CcSEcCtD
Methoxsalen—Rash—Carmustine—brain cancer	0.00055	0.00357	CcSEcCtD
Methoxsalen—Dermatitis—Carmustine—brain cancer	0.000549	0.00357	CcSEcCtD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000549	0.00388	CbGpPWpGaD
Methoxsalen—Headache—Carmustine—brain cancer	0.000546	0.00355	CcSEcCtD
Methoxsalen—Urticaria—Etoposide—brain cancer	0.000536	0.00348	CcSEcCtD
Methoxsalen—Body temperature increased—Etoposide—brain cancer	0.000533	0.00346	CcSEcCtD
Methoxsalen—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000532	0.00376	CbGpPWpGaD
Methoxsalen—Rash—Temozolomide—brain cancer	0.000531	0.00345	CcSEcCtD
Methoxsalen—Dermatitis—Temozolomide—brain cancer	0.000531	0.00345	CcSEcCtD
Methoxsalen—Headache—Temozolomide—brain cancer	0.000528	0.00343	CcSEcCtD
Methoxsalen—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000524	0.00371	CbGpPWpGaD
Methoxsalen—Nausea—Carmustine—brain cancer	0.000518	0.00336	CcSEcCtD
Methoxsalen—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000516	0.00365	CbGpPWpGaD
Methoxsalen—Nausea—Temozolomide—brain cancer	0.000501	0.00325	CcSEcCtD
Methoxsalen—Hypersensitivity—Etoposide—brain cancer	0.000497	0.00323	CcSEcCtD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000493	0.00349	CbGpPWpGaD
Methoxsalen—Pruritus—Etoposide—brain cancer	0.000477	0.0031	CcSEcCtD
Methoxsalen—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000458	0.00324	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CYP2C9—brain cancer	0.000455	0.00322	CbGpPWpGaD
Methoxsalen—Dizziness—Etoposide—brain cancer	0.000446	0.0029	CcSEcCtD
Methoxsalen—Rash—Etoposide—brain cancer	0.000425	0.00276	CcSEcCtD
Methoxsalen—Dermatitis—Etoposide—brain cancer	0.000425	0.00276	CcSEcCtD
Methoxsalen—Headache—Etoposide—brain cancer	0.000423	0.00274	CcSEcCtD
Methoxsalen—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.00042	0.00297	CbGpPWpGaD
Methoxsalen—Nausea—Etoposide—brain cancer	0.000401	0.0026	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—BSG—brain cancer	0.000387	0.00274	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00035	0.00247	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000339	0.0024	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000334	0.00237	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—IDH1—brain cancer	0.000333	0.00235	CbGpPWpGaD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	0.00032	0.00227	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000316	0.00224	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000285	0.00202	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ENO2—brain cancer	0.000263	0.00186	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000262	0.00185	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000258	0.00183	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000242	0.00171	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000223	0.00158	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000218	0.00154	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000218	0.00154	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000204	0.00145	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000202	0.00143	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000182	0.00129	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000154	0.00109	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000149	0.00106	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000142	0.00101	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000139	0.000983	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000139	0.000983	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00013	0.000921	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP2C9—brain cancer	0.000122	0.000864	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PIK3CG—brain cancer	0.000121	0.000854	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—BSG—brain cancer	0.000104	0.000734	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.52e-05	0.000674	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP2C9—brain cancer	9.09e-05	0.000644	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—IDH1—brain cancer	8.92e-05	0.000632	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—BSG—brain cancer	7.73e-05	0.000547	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ENO2—brain cancer	7.05e-05	0.000499	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—IDH1—brain cancer	6.65e-05	0.000471	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP2C9—brain cancer	5.8e-05	0.00041	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.41e-05	0.000383	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ENO2—brain cancer	5.26e-05	0.000372	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—BSG—brain cancer	4.93e-05	0.000349	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP2C9—brain cancer	4.48e-05	0.000317	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—IDH1—brain cancer	4.24e-05	0.0003	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—BSG—brain cancer	3.81e-05	0.000269	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.45e-05	0.000244	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ENO2—brain cancer	3.35e-05	0.000237	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—IDH1—brain cancer	3.27e-05	0.000232	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PIK3CG—brain cancer	3.24e-05	0.000229	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ENO2—brain cancer	2.59e-05	0.000183	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PIK3CG—brain cancer	2.41e-05	0.000171	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PIK3CG—brain cancer	1.54e-05	0.000109	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PIK3CG—brain cancer	1.19e-05	8.4e-05	CbGpPWpGaD
